SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.16-3.2%Dec 1 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16376)11/1/2003 1:50:41 AM
From: Cacaito  Read Replies (1) of 17367
 
Gw, you were right, Amevive price will drop soon...

RELATIVE to Enbrel effective high dose $14,500...

RELATIVE to the dreaded chronic therapy Raptiva $14,500...

vs CHEAP Amevive at $5,000 to $7,500 per year !

And in couple of years Biogen's Fumarate, ORAL new version to hit all the biologics in the chin !
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext